Seminars in Nuclear Medicine

Article	Citations
Theranostics in Lung Neuroendocrine Tumors	150
Imaging of Invasive Fungal Infections- The Role of PET/CT	135
Autoimmune Thyroid Diseases	121
FAPI-PET in Cardiovascular Disease	75
Letter from the Editors	70
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques	59
PET/CT in the Imaging of CNS Tumors	58
Non-FDG hypoxia tracers	52
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies	49
Sentinel Lymph Node Methods in Breast Cancer	45
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update	45
New Promising Targets for Imaging in Cardiovascular Diseases	44
Artificial Intelligence for Drug Discovery: An Update and Future Prospects	43
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled	41
CD70-Targeted Radiotheranostics: Now and Future	40
Prognostic Value of PSMA PET/CT in Prostate Cancer	38
Letter from the Editors	38
Imaging for Radiation Planning in Breast Cancer	37
The Role of Nuclear Medicine in Benign Thyroid Disease	37
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer	37
Molecular Imaging in Inflammatory Bowel Disease	36
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy	36
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity	35
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects	35
The Evolution of Artificial Intelligence in Nuclear Medicine	34

Total-Body PET/CT: A Role of Artificial Intelligence?	33
Global experience in brain amyloid imaging	33
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I	30
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma	29
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects	29
New Approaches for Imaging Bacteria	28
Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-19	28
Expanding Role for Gallium-68 PET Imaging in Oncology	27
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis	27
PET/MR Technology: Advancement and Challenges	26
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine	26
18F-Fluoride PET/CT—Updates	26
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology	25
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices	24
Letter from the Guest Editors	23
Letter From the Editors	23
Use of Radionuclide-Based Imaging Methods in Breast Cancer	23
Total-body PET/CT – First Clinical Experiences and Future Perspectives	23
The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma	22
Standardized PSMA-PET Imaging of Advanced Prostate Cancer	22
FDG PET/CT for Staging Lung Carcinoma: An Update	21
Update on Pediatric Nuclear Medicine in Acute Care	21
Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging	21
Radiolabeled Somatostatin Analogs for Cancer Imaging	21
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review	20
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases	20
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?	20
Nuclear Medicine Preclinical Research: The Role of Cell Cultures	20
Impact of COVID-19 on Nuclear Medicine in Asia	20
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine	19
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview	19
Artificial Intelligence Augmented Cerebral Nuclear Imaging	19
Targeted Radiopharmaceutical Therapy for Bone Metastases	19
Functional Imaging of Testicular Torsion	18
The Clinical Utility of Molecular Imaging in COVID-19: An Update	18
The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment	18
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends	18
Safe Pulmonary Scintigraphy in the Era of COVID-19	18
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?	18
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET	17
FDG-PET/CT Variants and Pitfalls in Haematological Malignancies	17
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma	17
Artificial Intelligence and Workforce Diversity in Nuclear Medicine	17
Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)	16
The Impact of COVID-19 on Nuclear Medicine in Europe	16
Letter from the Editors	15
Prostate Cancer Theranostics With 177Lu-PSMA	15
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma	15
Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-5	15
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace	15

Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case	15
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget	15
A Role of Non-FDG Tracers in Lung Cancer?	14
Letter From the Editors	14
PET/CT Variants and Pitfalls in Gynecological Cancers	14
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy	14
FDG-PET/CT of COVID-19 and Other Lung Infections	14
Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence	14
Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine	14
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides	14
COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?	14
Letter From the Guest Editors	13
How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers	13
Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging	13
Neuroimaging of Mild Traumatic Injury	13
Radiolabeled Antibody–Drug Conjugates in the Treatment of Solid Tumors	13
Advances in PET/CT Technology: An Update	13
Current Developments on [18F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System	13
Cardiac PET/MRI: Recent Developments and Future Aspects	13
Letter from the Editors	12
Letter from the Editors	12
SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases	12
Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational	12
Preclinical Evaluation of Novel PET Probes for Dementia	12
Total Body PET/CT: A Role in Musculoskeletal Diseases	12
Letter From the Editors	12
Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce	12
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting	12
Radiation Dose to Pediatric Patients From Radiopharmaceuticals	12
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging	12
Cardiovascular Imaging in Women	12
Letter from the Editors	12
PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [68Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis	12
FDG PET/CT for Staging and Restaging Malignant Mesothelioma	11
Letter from the Editors	11
Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[18F]FDG-PET/CT, 18F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone	11
Parathyroid Imaging	11
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma	11
Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging	11
Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy	11
The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update	11
Imaging of Bone Metastases in Breast Cancer	10
The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update	10
New Targets for Imaging in Nuclear Medicine	10
Molecular imaging Theranostics of Neuroendocrine Tumors	10
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine?	10
New Targets for Positron Emission Tomography Imaging in Parkinson´s Disease	10
Current and Future Perspectives of PDL1 PET and SPECT Imaging	10
Imaging of Endocarditis and Cardiac Device-Related Infections: An Update	10
New PET Tracers: Current Knowledge and Perspectives in Lung Cancer	10
Glypican-3: Novel Theranostic Agent for Hepatocellular Carcinoma	9
The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review	9
AI in SPECT Imaging: Opportunities and Challenges	9
Pitfalls of Radionuclide Renal Imaging in Pediatrics	9
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies	9
Clinical Management of COVID-19 Patients – An Update	9
Implementation of Radiotheranostics: Challenges, Barriers, and IAEA-Driven Strategies for Sustainable Access	9
FDG PET/CT Imaging of Sarcoidosis	8
Combination Strategies and Targeted Radionuclide Therapies	8
Letter From the Editors	8
Letter from the Editors	8
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers	8
The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?	8
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer	8
The Current Role of Tau PET Imaging in Neurodegeneration	8
Advances in PSMA Alpha Theragnostics	8
Imaging Approach to Disease of the Pleura	8
Advancement in Production of Radiotracers	8
Application of Deep Learning in Breast Cancer Imaging	8
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma	8
Letter from the Editors	8
Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain	7
Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review	7
Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer	7
PET/CT in Bladder Cancer: An Update	7
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer	7
Letter From the Editors	7
Letter from the Editors	7
Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends	7
Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging	7

The Role of AI in the Evaluation of Neuroendocrine Tumors: Current State of the Art	7
Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients	7
Preclinical Imaging Studies: Protocols, Preparation, Anesthesia, and Animal Care	7
Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma	7
Clinical Use of PET/MR in Oncology: An Update	7
Molecular Imaging of Tuberculosis	7
Present status and future trends in molecular imaging of lymphocytes	6
The Role of [18F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer	6
Vulnerable Plaque Imaging	6
Total-Body PET/CT: Pros and Cons	6
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: An Update on Dose Recommendations and Risk of Secondary Primary Malignancies	6
Molecular Imaging of Fever of Unknown Origin: An Update	6
Total Body PET-CT Protocols in Oncology	6
Potential of Technetium and Rhenium Theranostics	6
PET/CT in Hodgkin Lymphoma: An Update	6
Molecular Imaging of Pituitary Tumors	6
[177Lu]Lu-FAPI Radioligand Therapy: Emerging Horizons and Clinical Promise in Solid Tumors: A Comprehensive Review	6
Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update	6
Diuretic Renal Scintigraphy in Adults: Practical Aspects and Reporting	6
18F-FDG PET/CT for Response Assessment in Lung Cancer	6
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma	6
How to Report PSMA PET	6
Impact of PSMA PET on Radiation Oncology Planning	6
Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer?	6
Mucin-Targeted Antibodies for Ovarian Cancer	6
The Impact of Radiopharmaceutical Therapy on Renal Function	6